New Jersey lawmakers have advanced a bill provide adults with regulated therapeutic access to psilocybin with appropriate health conditions, with the intention of continuing to work to enact it in the 2026 legislative session.
More than a year after the House Health Committee first took up and amended the legislation — sponsored by Reps. Herb Conaway (D), Clinton Calabrese (D) and Anthony Verrelli (D) — the panel met Monday, taking testimony and benefiting from it.
“We’re all broke in one way, shape or form,” Verrelli (D), one of the bill’s sponsors, said at Monday’s hearing. “This bill gives people another chance to heal and improve. And if they get better, it gives them an opportunity to improve their communities, their families and their lives in general, to break that cycle of trauma, whatever it looks like.”
The committee amended the legislation last year to match the Senate version. To the disappointment of the defenders, however, this meant removing provisions that would have more broadly legalized psilocybin for adult use.
The plan, which included the personal legislative provisions that were originally introduced in the same form as the one proposed by lawmakers in the 2024 session, has recently been released in amended versions. Those ingredients would make it legal for adults to “possess, possess, use, ingest, inhale, process, transport, deliver without consideration, or distribute without consideration” four grams or less of psilocybin.
The amended measures, however, would significantly expand legislation introduced in late 2020 to reduce penalties for possessing an ounce of psilocybin. That reform Governor Phil Murphy (D) signed it into law in 2021
Stacy Swanson, who testified on behalf of Veterans Exploring Treatment Solutions (VETS), emphasized at Monday’s hearing that “the invisible wounds of war don’t just affect the veteran, they affect the entire family.”
“This bill does not legalize recreational drugs,” he said. “It creates structured access that is clinically supervised, with the necessary integration and monitoring.”
In its modified version, The invoice It would charge the Department of Health (DOH) with regulating and licensing the manufacture, testing, transportation, delivery, sale and purchase of psilocybin. There would be five types of licenses: manufacturer, service center operator, testing lab, facilitator, and psilocybin worker.
The Psilocybin Advisory Committee would establish appropriate medical conditions for use, propose guidelines for psilocybin services and dosage, craft safety studies and informed consent practices, and oversee the education, training, and conduct of facilitators.
The stated goal would be to develop a long-term strategic plan for safe, accessible, and affordable access to psilocybin for those 21 and older.
Toward this end, a social equity program would include implementing grants to help low-income people cover the costs of psilocybin services. DOH would direct the implementation of programs for technical assistance, fee reduction and other support services.
Jesse McLaughlin, state advocacy director for Reason for Hope, said Monday hearing that psychedelic medicine represents “the next big step forward in psychiatry” and we need to prepare our healthcare system for it.
“Psilocybin therapy is time-intensive, labor-intensive and different from the way psychiatric care is delivered today,” he said.
To access psilocybin services under the bill, a patient with a qualifying condition would have to obtain a referral from a licensed health care professional. Services would also include mandatory preparation and integration sessions before and after psilocybin administration.
The Assembly bill is in the hands of the Appropriations Committee. The Friend the Senate has already cleared two panels in that chamber—Health, Human Services and Elderly Committee and Budget and Credit Committee.
A survey of New Jersey residents released last year bears this out A majority of state residents agree with making psilocybin available for therapeutic usealthough they were not specifically asked about the specific legislation.
The poll, by Stockton University’s William J. Hughes Center for Public Policy, found that 55 percent of respondents supported legalizing psilocybin for medical use under the supervision of a physician. Only 20% of respondents were against, and 24% were not sure. A percentage of respondents refused to answer the question.
—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.
Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—
In other New Jersey drug policy news, Voters earlier this month chose U.S. Rep. Mikie Sherrill (D-NJ) to be the state’s next governor.and now there’s a clearer path to the marijuana reform that consumers and advocates in the Garden State have long awaited: the option to grow it at home.
Meanwhile, as New Jersey’s first marijuana lounges opened this summerregulators shared information on where to find the sites and offered advice on the responsible use of cannabis in licensed businesses, including rock culture classics like “puff, puff, pass.”
New Jersey officials have also completed the curriculum for a no-cost marijuana training academy to help entrepreneurs interested in entering the cannabis industry.
Separately, in May, New Jersey Senate President Nick Scutari (D) introduced a bill that would recriminalize the purchase of marijuana from unlicensed sources-A last ditch effort to combat the illegal market and direct adults to licensed dealers.
In March, a former New Jersey Senate leader unsuccessfully ran for this year’s Democratic nomination for governor. “It’s time” to allow medical marijuana patients to grow their own cannabis plants for personal use. He also pledged to expand amnesty for people affected by the criminalization of marijuana, if elected, and supported the establishment of cannabis consumption halls.
The comments by Sweeney, the longest-serving Senate president in the state’s history, diverge from what the current governor has repeatedly said about home growing, arguing that the state’s adult marijuana market needs to mature more before allowing home growing.
That claim appears to be contradicted by dozens of small marijuana businesses and advocacy groups in New Jersey recently He asked Parliament to allow adults to grow their own cannabis.
user photo CostaPPR.